article thumbnail

Cipla founding family’s stake sale in jeopardy over $13 billion valuation target

CFO News

Prospective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding family. Negotiations have stalled as the family is seeking about 1,350 rupees per share, representing a 10% premium over the current price.

article thumbnail

M&A deal activity set to pick up this year, may touch $75 billion: Ganeshan Murugaiyan, BNP Paribas

CFO News

Indian M&A activity set to rise to $75 billion in 2024, driven by private equity, IT, core industrial space, and pharmaceuticals, with influences from cross-border deals, M&A valuations, equity, debt markets, and IPOs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mankind Pharma set for stellar debut on Tuesday, Street sees 8-10% listing premium

CFO News

Although Mankind Pharma is the fourth-largest Indian pharmaceutical company in terms of domestic sales, investors are advised to book profits on listing day given the expensive valuations of the stock versus peers.

article thumbnail

Six Flags, Rivian, Bumble, Coinbase, Dutch Bros and more

CFO News Room

Additionally, Morgan Stanley reiterated it as overweight, noting hardware subscriptions as a key catalyst for moving the market toward a loan-to-value valuation. AstraZeneca – The pharmaceutical company added 6.6% Apple – Shares of the technology giant gained 8.9% as rates dropped, lifting the broader tech sector.

article thumbnail

Musings on Markets: META Lesson 3: Tell me a story!

CFO News Room

As someone who has spent the last four decades talking, teaching and doing valuation that we have lost our way in valuation. Even as data has become more accessible and our tools have become more powerful, it is my belief that the quality of valuations has degraded over time.

Marketing 130
article thumbnail

Musings on Markets: META Lesson 2: Accounting Inconsistencies and Consequences

CFO News Room

That skewing can affect valuation and pricing judgments about these firms, and correcting accounting inconsistencies is a key step towards leveling the playing field. I believe it is, since failure to do so can have both valuation and pricing consequences.

article thumbnail

The Difference Makers: Key Person(s) Valuation

Musings on Markets

Of course, and with small businesses, especially those built around personal services (a doctor or plumber’s practice), it is part of the valuation process, where the key person is valued or at least priced and incorporated into valuation. To estimate key person value, there are three general approaches: 1.

Valuation 113